Shanghai Longwood Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Shanghai Longwood Biopharmaceuticals Co., Ltd., explained in plain language.
-
New pill tested to tame severe arthritis flares
Disease control CompletedThis study tested a new pill called LW402 to see if it could help control rheumatoid arthritis. It involved 72 adults who still had active, painful arthritis despite taking a standard medication (methotrexate). Participants took either LW402 or a placebo (dummy pill) for 12 weeks…
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New eczema drug shows promise in reducing severe skin symptoms
Disease control CompletedThis study tested whether an experimental drug called LW402 can reduce symptoms of moderate-to-severe eczema (atopic dermatitis). 144 patients with significant eczema coverage received either the drug or a placebo for 12 weeks. Researchers measured how much skin redness, thicknes…
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC